Splenic FDG PET uptake and CT volume as prognostic biomarkers in diffuse large B cell lymphoma
{{output}}
Objectives: To evaluate whether baseline splenic ^18F-FDG PET uptake and CT-derived spleen volume predict early progression (≤ 36 months) and progression-free survival (PFS) in diffuse large B cell lymphoma (DLBCL), and whether ... ...
